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Forced Expression of LIM Homeodomain Transcription
Factor 1b Enhances Differentiation of Mouse
Embryonic Stem Cells into Serotonergic Neurons
Virginie Dolmazon,1–3 Natalia Alenina,4 Suzy Markossian,1–3 Jimmy Mancip,1–3
Yvonne van de Vrede,1–3 Emeline Fontaine,1–3 Colette Dehay,1–3 Henry Kennedy,1–3
Michael Bader,4 Pierre Savatier,1–3 and Agnieszka Bernat1–3
The LIM homeodomain transcription factor 1b (Lmx1b) is a key factor in the specification of the serotonergic
neurotransmitter phenotype. Here, we explored the capacity of Lmx1b to direct differentiation of mouse embry-
onic stem (mES) cells into serotonergic neurons. mES cells stably expressing human Lmx1b were generated by
lentiviral vector infection. Clones expressing Lmx1b at a low level showed increased neurogenesis and elevated
production of neurons expressing serotonin, serotonin transporter, tryptophan hydroxylase 2, and transcription
factor Pet1, the landmarks of serotonergic differentiation. To explore the role of Lmx1b in the specification of the
serotonin neurotransmission phenotype further, a conditional system making use of a floxed inducible vector
targeted into the ROSA26 locus and a hormone-dependent Cre recombinase was engineered. This novel strategy
was tested with the reporter gene encoding human placental alkaline phosphatase, and demonstrated its capacity
to drive transgene expression in nestinþ neural progenitors (NPs) and in Tuj1þ neurons. When it was applied to
inducible expression of human Lmx1b, it resulted in elevated expression of serotonergic markers. Treatment
of neural precursors with the floor plate signal Sonic hedgehog further enhanced differentiation of Lmx1b-
overexpressing NPs into neurons expressing 5-HT, serotonin transporter, tryptophan hydroxylase 2, and Pet1,
when compared with Lmx1b-nonexpressing progenitors. Together, our results demonstrate the capacity of Lmx1b
to specify a serotonin neurotransmitter phenotype when overexpressed in mES cell-derived NPs.
Introduction
Embryonic stem (ES) cells have the capacity to differen-tiate into a large variety of cells types in vitro, owing to
their high self-renewal capacity and intrinsic pluripotentiality
[1]. ES cells can be used to dissect the molecular mechanisms
underlying in vitro differentiation into specialized cell types,
such as serotonergic neurons. Several protocols to coax dif-
ferentiation of mouse, rhesus, and human ES (hES) cells into
neural progenitors (NPs) and then to direct differentiation of
those progenitors into serotonergic neurons have been de-
scribed [2–7]. These protocols make use of growth factors and
cytokines known to regulate serotonergic differentiation in
the mouse central nervous system. Implicit to this experi-
mental paradigm, the developmental program employed by
ES cells to differentiate into serotonergic neurons in vitro,
largely, if not fully, recapitulates the developmental program
executed during neurogenesis in the developing embryo.
Serotonergic (5-HT) neurons reveal a close ontogenetic re-
lationship to midbrain dopaminergic (DA) neurons as both
neuronal subtypes derived from ventral neuroepithelial pro-
genitors located on either side of the midbrain–hindbrain
boundary, starting at embryonic day 10.5 in the mouse [8–10].
According to the prevailing model, the development of both
5-HT depends critically on sonic hedgehog (Shh) synthesized
by the floor plate, fibroblast growth factor 8 (FGF8) generated
by the midbrain–hindbrain organizer, and FGF4 produced by
the primitive streak [11,12]. NPs located more rostrally, thus
away from the FGF4 signal, differentiate into DA neurons.
Several transcription factors are involved in serotonergic
differentiation. Mash1 and Nkx2.2 expressed in NPs of the
hindbrain activate the transcription factors Gata2, Gata3,
LIM homeodomain transcription factor 1b (Lmx1b), and Pet1
[13], which together define the serotonergic cell type by ac-
tivating marker genes such as for tryptophan hydroxylase 2
(TPH2), aromatic amino acid decarboxylase, the serotonin
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transporter (SERT), and the vesicular monoamine trans-
porter 2 [14]. Both Gata2- and Gata3-deficient mice exhibit
partial loss of serotonergic neurons [13,15]. In mice lacking
Pet1, 70% of serotonergic progenitors fail to differentiate,
whereas in the remaining Pet1-deficient neurons diminished
expression of TPH and SERT was observed [16]. Lmx1b is
crucially involved in the formation of the entire serotonin
system in the hindbrain, because its deletion in mice leads to
the absence of 5-HT neurons in the brain [17–19]. It is ex-
pressed in developing 5-HT neurons together with Pet1
starting around E11 in the rostral cluster of serotonergic
differentiation and 1 day after in the caudal one, consistent
with the delayed appearance of serotonergic cells in the latter
region [18]. Lmx1b ablation does not affect expression of
Nkx2.2, Gata3, and Shh, putting these factors upstream of
Lmx1b [17,18]. Together with Nkx2.2, GATA3, and Pet1,
Lmx1b can induce ectopically the development of serotoner-
gic neurons in the chick neural tube, a function that Nkx2.2
and Pet1 cannot support on their own [18,20]. Lmx1b is also
involved in the maintenance of the DA neurotransmitter
phenotype in collaboration with the orphan nuclear receptor
Nurr1 [21]. Therefore, Lmx1b plays a central role in the dif-
ferentiation of 5-HT neurons, and an ancillary role in the
differentiation of midbrain DA neurons.
Differentiation of mouse ES (mES) cells into serotonergic
neurons is highly efficient. In a pioneer study, sequential
exposure of mES cell-derived nestinþ NPs to FGF4 and then
to FGF8 and Shh led to a 2.5-fold increase in the number of
serotonergic neurons resulting in*25% of the neurons being
5-HT positive [22]. Using stromal cell cultures to induce
differentiation of mES cells and adding the same combina-
tion of factors, Barberi et al. were able to define conditions in
which the mouse ES cells were differentiated into 60% 5-HT
expressing neurons [3]. Similar results were obtained with
hES cells. Under nonoptimized differentiation conditions,
<1% of the hES cell-derived neurons obtained are serotonin
positive [23,24]. Addition of factors that included Shh, FGF4,
FGF8, glial-derived neurotrophic factor, and brain-derived
neurotrophic factor increased the number of 5-HT expressing
cells to 25% of the b-III-tubulin-positive cell population. In a
recent study, 40% of NPs could be converted to serotonergic
neurons expressing serotonin, Tph2, and the transcription
factors Mash1, Pet1, and Lmx1b [6].
Herein, we asked if overexpression of Lmx1b expression is
sufficient to drive differentiation of mES cell-derived NPs to
the serotonergic neuron pathway. We developed 2 experi-
mental approaches, the first one based on lentiviral vector-
based stable expression and the second one on conditional
expression induced by 40hydroxytamoxifen (40OHT) in NPs.
In both experimental systems, Lmx1b was found to promote




To engineer pR4SA-EFS-CreERT2-W, the Cre-ERT2 coding
sequence from pCre-ERT2 [25] was subcloned between
the EcoRV and BamHI sites of plasmid pR4SA-EFS-GFP-W [26].
To engineer p2K7-HAhLmx1b, the human Lmx1b cDNA
from pcDNA3.1hLmx1b (a kind gift from S. Dreyer) was first
HA tagged at its N-terminus by polymerase chain reaction
(PCR) amplification. It was subsequently subcloned between
BamHI and EcoRV sites in plasmid pGAE-CAG-eGFP-WPRE
[27]. In a second step, the CAG promoter (CMV early en-
hancer=chicken b-actin) from pGAE-CAG-eGFP-WPRE was
cloned into pDONRP4-P1R (Invitrogen), and the HAhLmx1b
cDNA from pGAE-CAG-HAhLmx1b-WPRE was cloned into
pDONR221 (Invitrogen), both using Gateway BP clonase
enzyme mix (Invitrogen). The resulting 2 entry vectors were
then recombined into 2K7neo lentivector (kind gift of D. Su-
ter) using Gateway LR plus clonase enzyme mix (Invitrogen)
[28].
To engineer pIGTE2-R26-hPLAP, a 48-mer oligonucleo-
tide containing a PacI site (50-attttaattaagaagttcctattctctag
aaagtataggaacttcgat-30) and a 54-mer oligonucleotide con-
taining an AscI site (50-ctagagctagcgaagttcctattcttcaaatagtat
aggaactt cggcgcgcca-30) were first subcloned into the SspI
and AscI sites of plasmid pIGTE2-hAP [29], respectively. The
resulting plasmid was digested with PacI and AscI, and the
3.8 kb fragment was subcloned between PacI and AscI in
pRosa26PA [30] to generate pIGTE2-R26-hPLAP. To engineer
pIGTE2-R26-hLmx1b, a 1.2 kb NheI=XbaI fragment en-
compassing human Lmx1b cDNA was prepared from
pcDNA3.1hLmx1b (a kind gift from S. Dreyer), and sub-
cloned in pCMV-Ires-pA to generate pCMVhLmx1b. The
pCMVhLmx1b plasmid was next digested with NheI, and the
resulting 2.9-kb insert was subcloned between both NheI
sites into pIGTE2 to generate pIGTE2-hLmx1b. PacI and AscI
sites were added as described above for pIGTE2-hAP, and
the resulting PacI=AscI fragment was subcloned between
PacI and AscI in pRosa26PA to generate pIGTE2-R26-
hLmx1b.
mES cell culture and electroporation
mES cells (CGR8) were maintained on 0.1% gelatinized
(Sigma) tissue culture dishes in Glasgow’s modified Eagle’s
medium supplemented with 10% fetal calf serum (Biowest),
1,000U=mL of leukemia inhibitory factor (LIF), 1mM so-
dium pyruvate, 2mM L-glutamine, 100U=mL penicillin–
100mg=mL streptomycin, and 100 mM b-mercaptoethanol (all
from Invitrogen). About 5106 CGR8 cells were electro-
porated at 0.26 kV and 960 mF with 40mg of pIGTE2-R26-
hPLAP or pIGTE2-R26-hLmx1b plasmid linearized with SwaI.
Stably transfected cells were selected with 80 mg=mL hygro-
mycine B (Roche Applied Science) for 8 days. Drug-resistant
colonies were expanded before analysis and frozen.
Neuronal differentiation
Neural induction and neuronal differentiation were per-
formed by means of coculture of mES cells with the MS5
stromal cell line as previously described [3]. In brief, mES
cells were seeded at a density of 10–50 cells=cm2 on the layer
of mitomycin-inactivated MS5 cells, and maintained in
knockout Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 15% (vol.=vol.) knockout serum re-
placement, 2mM L-glutamine, and 10mM b-mercaptoethanol
(all from Invitrogen), for 8 days to allow neural induction.
Neuroepithelial colonies were harvested with a fire-pulled
Pasteur pipette, dissociated by gentle trypsinization, and
replated on Matrigel (BD Biosciences)-coated dishes in
Neurobasal medium without phenol red, supplemented with
200mM glutamine, 5mg=mL bovine fibronectin, N2 and B27
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supplement (all from Invitrogen), and 20 ng=mL FGF2
(AbCys). FGF4 (100 ng=mL), FGF8 (100 ng=mL), and SHH
(200 ng=mL) (R&D Systems) were added to the culture
medium at times indicated. To induce neuronal differenti-
ation, FGF2 was withdrawn from the medium at day 11–12,
and replaced with 20 ng=mL brain-derived neurotrophic
factor (R&D Systems), 200 mM ascorbic acid (Sigma), and
20 ng=mL neurotrophin 3 (R&D Systems). Final differenti-
ation was allowed for 5–6 days. 40OHT (Calbiochem) was
added to the culture medium for the time and concentration
indicated.
Neural differentiation was also induced by the formation
of embryoid bodies (EBs) as previously described [5,31,32]. In
brief, 6106 ES cells were cultured in suspension in 10mL of
the medium (Glasgow’s modified Eagle’s medium supple-
mented with 10% vol.=vol. knockout serum replacement,
2mM L-glutamine, 1mM sodium pyruvate, and 1 non es-
sential amino acids (NEAA); all from Invitrogen) in a 10-cm
dish. After 8 days, EBs were dissociated and replated at a
density of 2.5104 cells=cm2 on poly-d-lysine=laminin (Sigma)
in the N2B27 medium (Invitrogen). After replating, neural
precursor cells were enriched for 2 days by the addition of
10ng=mL FGF2 (R&D Systems). Withdrawal of FGF2 in the
N2B27 medium resulted in production of postmitotic neurons
(from day 11 to 18).
Production of lentiviral vectors and infection
The method for simian immunodeficiency virus (SIV)-
based vector production in 293T cells is fully described
elsewhere [26,33]. In brief, 293T cells were transfected by the
calcium phosphate method with a mixture of DNA con-
taining pGRev plasmid encoding the vesicular stomatitis vi-
rus glycoprotein envelope, pSIV3þ plasmid encoding the
gag, pol, tat, and rev proteins, and pR4SA-EFS-CreERT2-W.
The next day, cells were refed with the fresh medium and
further cultured for 48 h. The supernatant was then collected,
cleared by centrifugation (3,000 rpm and 15min), and passed
through a 0.8-mM filter to remove cell and debris. For infec-
tion, 104 freshly trypsinized mES cells were resuspended into
1mL of 293T cell supernatant producing the desired virus in
the presence of 8mg=mL sequabrene (Sigma), plated on a 2-cm-
diameter dish, and cultured for 48h before cloning by limiting
dilution. The production of lentiviral particles from plasmid
p2K7neo-HAhLmx1b was performed as described [28,34].
DNA and RNA extraction, Southern blot,
and real-time PCR
For genomic DNA extraction, cells were lysed in 10mM
Tris-HCl (pH 8), 1mM ethylenediaminetetraacetic acid (pH
8), 100mM NaCl, and 0.5% sodium dodecyl sulfate. The
resulting lysate was treated with 0.2mg=mL RNase for 1 h
at 378C, followed by proteinase K treatment (0.2mg=mL,
558C, overnight). DNA was separated from proteins by
phenol–chloroform extraction, precipitated with isopro-
panol, and resuspended in 1mM Tris-HCl and 0.1mM
ethylenediaminetetraacetic acid (pH 8). Ten micrograms of
EcoRV-digested genomic DNA was separated on a 0.8%
agarose gel, transferred to a nylon membrane (Hybond-Nþ;
Amersham), and hybridized with 32P-labeled (Ready-to-Go
Labeling Kit; Amersham) probe. RNA was extracted using
RNAeasy kit (Qiagen) with on-column DNAse (Qiagen)
digestion, and reverse transcription carried out with MuMLV-
RT (Promega) according to the manufacturer’s rec-
ommendations. Quantitative PCR was performed using the
LightCycler 1.5 system and the LightCycler Fast Start
DNA Master SYBR Green I kit (Roche Applied Science)
according to the manufacturer’s instructions. Reactions were
carried out in a total volume of 10 mL, comprising 0.4 mM of
each primer, 0.75 mL SYBR Green, 2.5 mL of diluted cDNA,
and 2–4mM MgCl2 according to primers. Amplification
and online monitoring was performed using the Light-
Cycler 1.5 system. After 40 amplification cycles, melt-curve
analyses were performed to verify that only the desired
PCR product had been amplified. PCR efficiency of both the
target and reference genes was calculated from the derived
slopes of standard curves by LightCycler software (Roche
Molecular Biochemicals; LightCycler Software, version 3.0).
These PCR efficiency values were used to calculate the
relative quantification values for calibrator-normalized
target gene expression by LightCycler relative quan-
tification software (version 1.0). All normalizations were
carried out with b-actin. Semiquantitative PCR was per-
formed using Euroblue Taq polymerase according to sup-
plier (Eurobio) instructions. Sequences of primers are
given in Supplementary Table S1 (available online at www
.liebertonline.com/scd).
Histochemical detection and immunolabeling
Histochemical analysis for hAP expression in cultured
cells and quantification of hAP activity in protein lysates
were carried out as described previously [29]. For im-
munolabeling, cells were washed in phosphate-buffered
saline (PBS) and fixed in 4% paraformaldehyde in PBS at
room temperature for 30min. After the rinse with PBS, cells
were permeabilized in 0.2% Triton X-100 in PBS for 15min.
Nonspecific binding was blocked with nonimmune normal
goat serum (Zymed) for 30min at room temperature. Pri-
mary antibodies were applied in 1% normal goat serum
(Invitrogen) in PBS. The following primary antibodies were
used: human placental alkaline phosphatase (hPLAP; Sigma),
b-III-tubulin (Chemicon and Covance), PSA-NCAM (Chemi-
con), and 5-HT (Sigma). After incubation at 378C for 1 h,
followed by several rinses in PBS, appropriate fluorochrome-
conjugated secondary antibodies were added (Molecular
Probes). The cells were incubated at 378C for 30min and, after
extensive washes in PBS, mounted on glass microscope slides
using Vectashield HARD mounting medium (Vector Labs,
Inc.) containing DAPI for DNA counterstaining.
Enzyme-linked immunosorbent assay
To evaluate the 5-HT level in postmitotic neuronal culture,
cells were lysed in PBS containing 0.1% ascorbic acid (Sigma)
by repeated freezing (808C) and thawing. The extracts were
sonicated and separated from debris by centrifugation (30min
14,000 rpm). The protein concentration was estimated using
Coomassie blue staining. Enzymatic immunoassay for 5-HT
was performed with nano-detection kit Serotonin EIA BA
10-0900 (Labor Diagnostika Nord) following manufacturer’s
instructions. Serotonin concentration measured with the EIA
kit was normalized to total protein content.
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Results
Neuronal differentiation of mES cells
overexpressing Lmx1b
CGR8 mES cells were infected with p2K7-HAhLmx1b, a
lentiviral vector expressing human Lmx1b cDNA driven by
the ubiquitous CAG promoter. Clones expressing hLmx1b at
low (L1, L2, L3, L4, L9, and L10), intermediate (L5, L6, L7, L8,
and L12), and high (L11) levels were isolated (Fig. 1A). They
were cultured onto MS5 stromal cells for 8 days to form
neuroepithelial colonies, which were subsequently dissociated
and replated on Matrigel-coated dishes in the presence of
FGF2 to amplify a morphologically homogenous population
of NPs, which is uniformly immunoreactive for NP-specific
antigens such as nestin and PSA–NCAM [3] (hereafter called
MS5 protocol). NPs were induced to differentiate into Tuj1þ
neurons by withdrawal of FGF2 for 4–6 days (data not
shown). We observed that hLmx1b expression dramatically
influenced both the yield of neuroepithelial colonies at day 8
and the yield of NPs after colony dissociation and replating at
day 12. More specifically, clone L11 (high expressor) produced
significantly smaller neuroepithelial colonies in comparison
either with control mES cells (56% reduction in size) or with
low expressor L1 (43% reduction) (Fig. 1B, C). Of note, the
number of neuroepithelial colonies did not vary significantly
between clones, indicating that hLmx1b expression did not
interfere with clonigenicity and survival of dissociated mES
cells in these culture conditions (data not shown). We thus
hypothesized that hLmx1b overexpression altered proliferation
and=or survival of transient amplifying NPs. This hypothesis
was confirmed after counting NPs upon dissociation of neu-
FIG. 1. Neuronal differentiation of mouse embryonic stem (mES) cells overexpressing human LIM homeodomain tran-
scription factor 1b (hLmx1b). (A) Real-time polymerase chain reaction (PCR) analysis of hLmx1b mRNA level in mES cell
clones (L1–L12) infected with p2K7-HAhLmx1b. (B) Neuroepithelial colonies at day 8 of differentiation formed by clones L1,
L11, and control cells, MS5 protocol. Scale bar: 100 mm. (C) Surface of neuroepithelial colonies at day 8 of differentiation in
clones L1 and L11, and in control cells (MS5 protocol). (D) Counting of neural progenitors (NPs) at day 12 of differentiation
obtained with clones L1 and L11, and control cells (MS5 protocol). (E) Real-time PCR analysis of Map2ab expression levels at
day 15 of differentiation with clones L1 and L2, and with control cells (MS5 protocol) after normalization with p-actin. (F)
Real-time PCR analysis of Tuj1 expression levels at day 17 of differentiation in clones L1 and L3, and with control cells
(embryoid body protocol). (G) Semiquantitative reverse transcriptase (RT)-PCR analysis of HA-hLmx1b expression in clones
L1 and L2, and in control cells, at day 0 (mES cells), day 8 (neuroepithelial colonies), and day 15 (postmitotic neurons) (MS5
protocol). (C–F) Histograms represent means and standard errors calculated in 3 replicates. Statistical significance was
determined with the unpaired two-sided t-test (*P< 0.05; **P< 0.01; ***P< 0.001). (A, E, F) Expression levels are normalized
to the level measured in e12.5 total brain.
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FIG. 2. Serotonergic and dopaminergic differentiation of mES cells overexpressing hLmx1b (embryoid body protocol). Real-
time PCR analysis of tryptophan hydroxylase 2 (Tph2), serotonin transporter (SERT) and Petl (A), tyrosine hydroxylase (TH),
Lmx1a, and Isl1 (C), mRNA levels in clones L1 and L3, and in control cells, at day 17 of differentiation. Expression levels are
normalized to Tuj1 and then to the level measured in e12.5 total brain. (B) Double immunofluorescence analysis of Tuj1
(green)- and 5-HT (red)-positive neurons, performed at differentiation day 15 of clones L1 and L3, and control cells. Nuclei
are labeled with DAPI. Scale bar: 250mm. (D) Quantification of 5-HT in cell extracts of neuron cultures at day 17 of
differentiation by serotonin enzyme-linked immunosorbent assay. (A, C, D) *P< 0.05; **P< 0.01; ***P< 0.001.
FIG. 3. Generation of an inducible expression vector and ES cell line for conditional gene expression. (A) Schematic
representation of the ROSA26 locus after targeted integration of pIGTE2-R26-hPLAP plasmid before and after Cre-mediated
excision of the hygro-polyA cassette. The position of the SacII-PacI probe used for Southern blot analysis is indicated. HygroR,
gene conferring resistance to hygromycin B; PolyA, transcription termination and polyadenylation signals. (B) Southern blot
analysis of the ROSA26 locus after digestion with EcoRV and hybridization with a radioactive probe. (C) Human placental
alkaline phosphatase (hPLAP) activity measured in 3 independent undifferentiated WTC15-R26-hPLAP clones before and
after treatment with 100 nM 40hydroxytamoxifen (40OHT) for 48 h. (D) Southern blot analysis of the ROSA26 locus in WTC15-
R26-hPLAP-7 clone after digestion with EcoRV, before and after treatment with 40OHT (100 nM, 48 h). (E) Immuno-
fluorescence analysis of hPLAP expression in NPs and postmitotic neurons before and after treatment with 40OHT (100 nM,
48 h). Low panels show DAPI staining of DNA. Scale bar: 100 mm.
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roepithelial colonies at day 8, and subsequent culture for 4
days. Clone L11 (high expressor) exhibited a 50% reduction in
the yield of nestinþ NPs at day 12 compared with wild-type
ES cells (Fig. 1D). Moreover, after withdrawal of FGF2, most
L11-derived NPs failed to differentiate into mature neurons
and degenerated (data not shown). In sharp contrast, clone L1
(low expressor) produced a 63% increase in nestinþ NP
number at day 12 (Fig. 1D) and, at day 15 (ie, 3 days after
mitogen withdrawal), a 12-fold increase in pan-neuronal
marker Map2ab expression. Comparable results were ob-
tained with the low expressor L2 (Fig. 1E).
Similar data were obtained after neuronal differentiation in-
duced by formation of EBs for 8 days, followed by replating for
2 days in the presence of FGF2, and subsequent mitogen with-
drawal for 7 days (EB protocol). Compared with control cells,
the low expressors L1 and L3 showed a 2.7- and 4-fold increase
in pan-neuronal marker Tuj1 expression, respectively (Fig. 1F).
Of note, hLmx1b was expressed at constant levels throughout
differentiation (Fig. 1G). Together, these results suggest that
moderate overexpression of Lmx1b significantly increases the
yield of neural=neuronal differentiation of mES cells.
ES cells overexpressing Lmx1b show preferential
differentiation toward serotonergic lineage in vitro
We next wanted to determine if Lmx1b overexpression
influences differentiation of NPs into serotonergic, DA, and
motoneurons. The low expressors L1 and L3 were used in
this study as they both exhibited vastly elevated neuronal
differentiation compared to high expressors. Expression of
serotonergic-, DA-, and motoneuron-specific markers, after
differentiation induced by EB formation, was measured by
real-time PCR. Since both L1 and L3 clones showed differ-
ences in the yield of neuronal differentiation compared with
control cells (see Fig. 1), the expression level of each marker
was normalized to Tuj1 (in addition to b-actin) to eliminate
the bias resulting from overproduction of neurons by
hLmx1b-expressing clones. E12.5 dpc brain extract was used
as a reference throughout these experiments. Clones L1 and
L3 exhibited increased expression of serotonergic markers, 9-
and 3-fold for brain-specific serotonin producing enzyme
Tph2, 7.7- and 2.5-fold for serotonin transporter (SERT), and
2.2-fold for serotonergic neuron-specific transcription factor
Pet1 (only L1) (Fig. 2A). Of note, a slight increase in DA
markers tyrosine hydroxylase (TH) and Lmx1a was also evi-
denced, whereas expression of Isl1, a marker of motoneuron
differentiation, was significantly decreased (Fig. 2B). The en-
richment in serotonergic neurons at day 17 of differentiation
in Lmx1b-overexpessing clones was confirmed by immu-
nostaining against serotonin (Fig. 2C). Quantification of se-
rotonin level by enzymatic immunoassay showed a 20-fold
increase in 5-HT content in both L1 and L3 clones compared
with control cells (Fig. 2D). These results indicate that neural
precursors overexpressing hLmx1b at a low level show in-
creased propensity for differentiation into 5-HT neurons.
Generation of an inducible expression vector
and ES cells suitable for conditional gene
expression in NPs and postmitotic neurons
Since Lmx1b expression appeared detrimental to neural
differentiation when overexpressed at high levels in mES
cells, we generated an inducible expression system to drive
conditional expression of hLmx1b in the NP population. To
this aim, we made use of a hormone-dependant Cre-ERT2
recombinase and of an expression vector in which transgene
transcription is blocked by 3 floxed transcription termination
signals (Fig. 3A). This system displays 2 significant im-
provements with respect to our previously published system
[29]: (1) the Cre-ERT2 recombinase is expressed from a len-
tiviral vector in which the Cre-ERT2 coding sequence is dri-
ven by the ubiquituously active truncated version of the
EF1a promoter [26]; (2) the expression vector contains 7 kb of
genomic sequences that allow targeted integration into the
ROSA26 locus and subsequent transgene expression under
the ubiquitously active regulatory elements of ROSA26 [30].
A mES cell line expressing Cre-ERT2 was produced by in-
fection with pR4SA-EFS-CreERT2-W. This line, hereafter
called WTC15, expresses CreERT2 at high level in ES cells
and in their differentiated derivatives (data not shown).
Next, an inducible vector called pIGTE2-R26-hPLAP that
harbors hPLAP, the gene encoding hPLAP, was introduced
by electroporation into WTC15 cells. Ten individual hygro-
mycin-resistant clones were analyzed, of which 3 displayed
homologous recombination into the ROSA26 locus (Fig. 3B).
All 3 clones showed a 10- to 14-fold increase in hPLAP ac-
tivity upon treatment with 40OHT (100 nM, 48 h) (Fig. 3C).
One of them, hereafter called WTC-hPLAP-7, was selected
for further analysis. Treatment with 40OHT resulted in exci-
sion of the hygro-polyA cassette (Fig. 3D). Immuno-
fluorescence staining showed hPLAP expression in most cells
after treatment with 100 nM 40OHT for 48 h (Fig. 3E). Vir-
tually, no hPLAP-positive cells could be detected in the un-
treated cell population, indicating that transgene expression
was repressed completely in the absence of hormone.
WTC-hPLAP-7 cells were induced to differentiate into
neuroepithelial colonies by means of coculture with MS5
stromal cells for 8 days, followed by amplification of the NP
population by FGF2 for 3 days. To assess transgene induc-
tion in the neuroepithelial colonies, day 5 cultures were
treated with 100 nM 40OHT for 48 h. Expression of hPLAP
was subsequently observed in >95% of the neuroepithelial
colonies (Fig. 4A, panels b, c). Day 11 NPs, derived from
neuroepithelial colonies in which expression of the transgene
was induced at day 5, expressed hPLAP in virtually all cells
(Fig. 4A, panels e, f). Most neurons generated at day 17 also
expressed it (Fig. 4A, panels h, i). Analysis of hPLAP mRNA
level by real-time PCR showed a 49-fold increase in day 11
NPs and a 9-fold increase in postmitotic neurons after in-
duction with 40OHT at the ES cell stage (day 0). When in-
duction was performed at the neuroepithelial colony stage
(day 5), a 51-fold increase in day 11 NPs and a 22-fold in-
crease in postmitotic neurons were observed (Fig. 4B). To-
gether, these results show that once induced, either in the
undifferentiated state or during neural differentiation,
hPLAP expression level is maintained throughout neuronal
differentiation.
Inducible expression of Lmx1b in ES-derived
NPs stimulates neuronal production
A mES cell line conditionally expressing hLmx1b was en-
gineered by electroporating pIGTE2-R26-hLmx1b plasmid
into WTC15 mES cells. After selection, 9 hygromycin-
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resistant clone in 12 displayed targeted integration into the
ROSA26 locus (Fig. 5A, B). Two homologous recombinant
clones were tested, showing excision of the transcription
termination cassette after 40OHT treatment (100 nM, 48 h)
(Fig. 5C). Clone 6, hereafter called WTC-hLmx1b-6, was
chosen for all subsequent experiments. Real-time PCR anal-
ysis of hLmx1b expression in WTC-hLmx1b-6 showed a 55-
fold increase in mRNA level upon 40OHT induction at the ES
cell stage (day 0), and a 9- and 14-fold increase in postmitotic
neurons after induction at day 0 and at the neuroepithelial
colony stage (day 5), respectively (Fig. 5D). Of note, hLmx1b
expression levels in neurons produced from WTC-hLmx1b-6
ES cells after induction at day 5 were similar to expression
levels measured in hLmx1b-stably expressing clones L1 and
L2 (Fig. 5E). We also confirmed that the induction of hLmx1b
expression in WTC-hLmx1b-6 ES cell-derived NPs increased
Map2ab expression at day 18 (Fig. 5F), as it was observed
with hLmx1b-stable clones L1, L2, and L3 (see Fig. 1E, F).
Inducible expression of Lmx1b cooperates
with Shh, FGF4, and FGF8 to induce
serotonergic differentiation
We next asked whether the induction of hLmx1b expres-
sion in NPs promotes expression of serotonergic markers.
Expression of hLmx1b was induced in the neuroepithelial
colonies. After amplification in the presence of basic FGF,
NPs were induced to differentiate into postmitotic neurons
by mitogen withdrawal and the expression of serotonergic
markers analyzed by real-time PCR. mRNA levels measured
in the WTC-hLmx1b-6-derived neurons were normalized:
first, to pan-neuronal Map2ab marker level to eliminate var-
iations in the yield of neuronal differentiation; second, to
mRNA levels measured in the WTC-hPLAP-7-derived neu-
rons to eliminate nonspecific effects of 40OHT. We then ob-
served a 1.4-, 1.6-, and 2.5-fold increase of Pet1, Tph2, and
SERT mRNA levels, respectively (Fig. 6A).
Neuroepithelial colonies and amplifying NPs derived
from both WTC-hPLAP-7 and WTC-hLmx1b-6 were ex-
posed, either to Shh alone or to combinations of Shh and
FGF4 (day 5–8) followed by Shh and FGF8 (day 8–12). This
latter condition was described to promote serotonergic dif-
ferentiation [3,6]. Expression of hLmx1b and hPLAP
transgenes was induced by 40OHT in the developing neu-
roepithelial colonies at day 5. In the presence of Shh, in-
duction of hLmx1b expression—when it was compared to
induction of hPLAP—resulted in a 10-, 30-, and 55-fold in-
crease in Pet1, Tph2, and SERT expression levels in post-
mitotic neurons at day 18, respectively (Fig. 6B). Treatment
with Shh and FGF4, followed by Shh and FGF8, did not
further increase expression of Tph2 (31-fold) and SERT (57-
fold), and moderately increased expression of Pet1 (16-fold)
(Fig. 6C). Treatment with Shh combined with induced ex-
pression of hLmx1b also increased expression of DA markers,
En (2.8-fold), TH (18.5-fold), and Nurr1 (6.6-fold), when
compared with expression levels in Shh-treated control cells
(Fig. 6D). Further, addition of FGF4 and FGF8 to the dif-
ferentiation cocktail reduced expression of TH and Nurr1 by
FIG. 4. Conditional expression of hAP in neuroepithelial colonies, NPs, and postmitotic neurons. (A) Immunohistochemical
analysis of hAP expression in neuroepithelial colonies at day 8 (b, c), in NPs at day 11 (e, f), and in neurons at day 18,
following induction with 4’OHT (100 nM, 48 h), either in undifferentiated mES cells (b, e, h) or in neuroepithelial colonies at
day 5 (c, f, i). Left panels show unstained neuroepithelial colonies (a), NPs after immunolabeling for PSA-NCAM (green) (d),
and neurons after immunolabeling for Tuj1 (green) (g). DNA is counterstained with DAPI. Scale bar: 100mm. (B) Real-time
PCR analysis of hPLAP expression in ES cells after induction at day 0, in day 11 NPs after induction both at day 0 and at day
5, and in day 17 neurons after induction both at day 0 and at day 5. Expression levels are normalized to the level measured in
mES cells before induction. (**P< 0.01; ***P< 0.001).
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2-fold in comparison with Shh alone (Fig. 6E), which is likely
to reflect the capacity of FGF4 to inhibit DA differentia-
tion [11].
Taken together, these results show that enforced expres-
sion of Lmx1b, combined with Shh, robustly stimulates ex-
pression of serotonergic markers in the differentiating NPs
derived from mES cells.
Discussion
The focus of this study was to demonstrate the role of
Lmx1b in promoting differentiation of mES cell-derived NPs
into serotonergic neurons. Lmx1b is essential to the devel-
opment of the entire serotonergic system [17–19], as well as
to the maintenance of the DA neurotransmitter phenotype in
the mouse [21]. We thus asked if overexpression of Lmx1b
in mES cells is sufficient to specify serotonergic and DA
phenotypes.
Forced expression of a transgene that drives differentia-
tion often results in inability to form undifferentiated mES
colonies and consequent recovery only of low expressing or
deviant cells. We successfully generated mES cell lines that
express hLmx1b ectopically, but only the lines expressing it
at low level retained the capacity to differentiate into neural
precursors harboring the growth characteristics of control
cells. In contrast, mES cells expressing Lmx1b at high levels
exhibited reduced capacity to form NPs, and those progen-
itors to differentiate into postmitotic neurons. Failure to
differentiate could result either from the detrimental effect of
Lmx1b when overexpressed at elevated levels, or from the
selection of mutant mES cells that resisted to the differenti-
ation-promoting effect of Lmx1b. To overcome this difficulty,
FIG. 5. Conditional expression of hLmx1b in neurons. (A) Schematic representation of the ROSA26 locus after targeted inte-
gration of pIGTE2-R26-hLmx1b plasmid, before and after Cre-mediated excision of the hygro-polyA cassette. The position of the
SacII-PacI probe used for Southern blot analysis is indicated. HygroR, gene conferring resistance to hygromycin B; PolyA, tran-
scription termination and polyadenylation signals. (B) Southern blot analysis of theROSA26 locus after digestionwith EcoRV and
hybridization with a radioactive probe. (C) Southern blot analysis of the ROSA26 locus in WTC15-R26-hLmx1b-6 clone after
digestion with EcoRV, before and after treatment with 40OHT (100nM, 48h). (D) Real-time PCR analysis of hLmx1b expression in
neurons derived from WTC-Lmx1b-6 clone after induction with 4’OHT either at day 0 (undifferentiated ES cells) or at day 5
(neuroepithelial colonies). (E) Real-time PCR analysis of hLmx1b expression in neurons derived from WTC-Lmx1b-6 clone (after
induction with 40OHT at day 5) and in neurons derived from hLmx1b-stably expressing clones L1 and L2. (F) Real-time PCR
analysis ofMap2ab expression in neurons derived fromWTC-hPLAP-7 andWTC-hLmx1b-6 clone, after induction with 40OHT at
day 5. (E, F) Expression levels are normalized to the level measured in e12.5 total brain. (D, E, F) **P< 0.01; ***P< 0.001.
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we have engineered an inducible gene expression system
that makes possible to overexpress differentiation-promoting
genes in mES cell-derived NPs and to maintain their ex-
pression in differentiating neurons. Activation of hLmx1b in
mES cell-derived NPs and its subsequent expression in
postmitotic neurons, as revealed by the hPLAP reporter gene,
reflect the expression pattern of Lmx1b in the mouse, starting
in NPs of the hindbrain and being maintained in mature 5-
HT neurons [17].
In both stably induced and 40OHT-induced Lmx1b ex-
pressing mES cells, we observed that Lmx1b increases ex-
pression Tph2, SERT, and Pet1, the landmarks of serotonergic
neurotransmitter phenotype. The effect of Lmx1b was ob-
served using 2 different differentiation protocols, the first
one based on coculture of ES cells with a stromal feeder cell
line [3] and the second one based on EB formation [5], both of
them including selection and amplification of nestinþ NPs.
These results indicate that Lmx1b expression is rate limiting
for specifying the 5-HT phenotype, in accordance with the
genetic data in the mouse [17–19]. The inductive effect of
Lmx1b on serotonergic differentiation is strongly enhanced
when NPs are treated with the floor plate signal Shh. This
result can be explained by the capacity of Shh to activate
expression of ancillary factors acting in concert with Lmx1b
to promote serotonergic differentiation. Indeed, the specifi-
cation of serotonergic neurons requires a Shh-regulated
cascade of transcription factors to generate 5-HT neurons
in vivo. Shh-activated homeodomain proteins Nkx2.2 and
Nkx6.1 cooperate to induce closely related zinc-finger tran-
scription factors GATA2 and GATA3. Preceding the induc-
tion of 5-HT neurons, GATA2 activates both Lmx1b and Pet1
consistent with the timing of their expression in vivo
[17,18,20]. Ultimately, Pet1 contributes to serotonergic dif-
ferentiation since mice lacking Pet1 shows a loss of 70%–80%
of 5-HT neurons in the CNS [16], whereas Lmx1b knockout
mice lack all central 5-HT neurons [14,16,17]. In addition,
both Lmx1b and Pet1 have been shown to be necessary and
sufficient to specify 5-HT transmitter phenotype when
overexpressed in the chick ventral spinal cord [18]. Whether
Lmx1b and Pet1 act strictly in parallel to specify 5-HT neu-
rotransmitter phenotype [18], or whether Pet1 is also a target
gene of Lmx1b [17] is still unclear. During development,
FIG. 6. Inducible expression of hLmx1b in ES-derived NPs increases expression of serotonergic markers. (A–C) Real-time PCR
analysis of Petl, Tph2, and SERT mRNA levels in day 18 neurons derived from WTC-HLmx1b-6 clone after induction with
40OHT at day 5 (neuroepithelial colonies), in the absence of dorsoventralizing factors (A) or in the presence of sonic hedgehog
(Shh) (B) or in the presence of Shh, fibroblast growth factor 4 (FGF4), and FGF8 (C). (D, E) Real-time PCR analysis of En, TH,
and Nurrl mRNA levels in day 18 neurons derived from WTC-HLmx1b-6 clone after induction with 40OHT at day 5 (neu-
roepithelial colonies), either in the absence of dorsoventralizing factors (D) or in the presence of Shh, FGF4, and FGF8 (E). (A–E)
Expression levels are normalized to the level measured in e12.5 total brain. (A–E) *P< 0.05; **P< 0.01; ***P< 0.001.
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expression of Lmx1b precedes that of Pet1. Moreover, Pet1
expression is lost in Lmx1b knockout mice, raising the pos-
sibility that the maintenance of Pet1 expression is dependent
on Lmx1b [17,18]. Whether this reflects a loss of 5-HT neu-
rons or gene regulation by Lmx1b remained unclear. Inter-
estingly, the study of conditional deletion of Lmx1b at e12.5
showed that initiation of Pet1 expression is independent from
Lmx1b [18], but maintenance of its expression requires
Lmx1b [19]. Therefore, our observation that Pet1 expression
is moderately increased in neurons overexpressing hLmx1b
suggests that Pet1 is responsive to Lmx1b induction, and that
Lmx1b reinforces the transcriptional activity of Pet1 [17,18].
The development of 5-HT neurons depends critically on
FGF8 generated at the midbrain-hindbrain boundary and on
FGF4 produced by the primitive streak. In vivo, FGF4 in-
hibits the development of midbrain DA neurons and
promotes the development of 5-HT neurons [11]. In mES cell-
derived NPs treated with 40OHT to activate Lmx1b expres-
sion, addition of Shh, FGF4, and FGF8 has no effect on the
yield of serotonergic differentiation compared to a sister
culture treated with Shh alone. Thus, when Lmx1b is over-
expressed, FGF8 and FGF4 become dispensable for seroto-
nergic differentiation. This finding suggests that activation of
Lmx1b expression is the main consequence of FGF8 and
FGF4 induction in the developing NPs acquiring a 5-HT
phenotype.
Our experiments show that overexpression of Lmx1b, ei-
ther alone or in combination with Shh, has little or no effect on
the yield of DA neuron differentiation. This is in accordance
with a previous report [35] showing that transduction of
mouse and hES cells with Lmx1b does not induce maturation
to the midbrain DA neuron phenotype unless Nurr1 is co-
transduced in the same cell. Noteworthy, addition of FGF8
and FGF4 slightly reduced expression of midbrain DA neuron
markers in accordance with the function of FGF4 in vivo [11].
To summarize, our results underline the need for proper
extrinsic signals combined with intrinsic clues when engi-
neering and manipulating ES cells for differentiation pur-
poses. The vectors and cell lines described might be of great
value for studying the gene function in serotonergic neuron
development and disease pathology and in trying to un-
derstand how drugs that affect the serotonergic system alter
neurotransmitter release.
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